GUIDELINES FOR SUBMISSION

Before you begin, please prepare the following information:

• ​Presenting author’s contact details:
  • Full first and family name(s)
  • Email address
  • Affiliation details: department, institution/hospital, city, state (if relevant), country
  • Phone number
• Author and co-authors’ details
• Preferred Presentation type: Oral/Poster
• Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
• Abstract text – limited to 250 words including acknowledgments. Please note word count is affected when tables are included.
• Abstract topic– select the abstract topic per the list of topics.
• Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format.
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers, or other identifying information.
• The submission form allows storing your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
• Click on the SUBMIT button at the end of the process in order to submit your abstract. You can make changes to your submitted abstract by the deadline. After the submission deadline abstracts cannot be modified or corrected.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

ABSTRACT SUBMITTERS’ DECLARATION

During abstract submission, you will be asked to confirm that you agree to the following:

1. I confirm that I have previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission, and I am aware that it will be published as submitted.
2. Submission of the abstract constitutes the consent of all authors to publication (e.g. Conference website, programs, other promotions, etc.)
3. As the Abstract Submitter, I warrant and represent that I am the sole owner, or have the rights of all the information and content (“Content”) provided to  MDS 2025 and Kenes International (Hereafter: the “Organizers“), The publication of the abstract does not infringe any third-party rights including, but not limited to, intellectual property rights.
4. As the Abstract Submitter, I grant the Organizers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable nonexclusive basis.
5. I hereby confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
6. I understand that the presenting author must be a registered participant.
7. The Organizers reserve the right to remove from publication and/or presentation an abstract that does not comply with the above.
8. I understand that I must select a specific Theme, Topic, and/or Sub-Topic for my abstract allocation.  Although the Committee will work hard to honor this selection, this cannot be guaranteed.  The Committee reserves the right to change the Theme, Topic, or Sub-Topic under which the abstract was originally submitted.